Perspectives on host adaptation in response to Mycobacterium tuberculosis: modulation of inflammation.

[1]  A. C. Tanrıkulu,et al.  The Relationship Between Inflammatory Marker Levels and Pulmonary Tuberculosis Severity , 2014, Inflammation.

[2]  S. Kaufmann,et al.  Macrophage arginase-1 controls bacterial growth and pathology in hypoxic tuberculosis granulomas , 2014, Proceedings of the National Academy of Sciences.

[3]  G. De Libero,et al.  Nonclassical T cells and their antigens in tuberculosis. , 2014, Cold Spring Harbor perspectives in medicine.

[4]  H. Mollenkopf,et al.  AhR sensing of bacterial pigments regulates antibacterial defence , 2014, Nature.

[5]  A. Sher,et al.  Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk , 2014, Nature.

[6]  J. Friedland,et al.  Tuberculosis, pulmonary cavitation, and matrix metalloproteinases. , 2014, American journal of respiratory and critical care medicine.

[7]  H. Mollenkopf,et al.  Type I IFN signaling triggers immunopathology in tuberculosis-susceptible mice by modulating lung phagocyte dynamics , 2014, European journal of immunology.

[8]  S. Kaufmann,et al.  Tumor necrosis factor alpha in mycobacterial infection. , 2014, Seminars in immunology.

[9]  V. Sosunov,et al.  Gr-1dimCD11b+ Immature Myeloid-Derived Suppressor Cells but Not Neutrophils Are Markers of Lethal Tuberculosis Infection in Mice , 2014, The Journal of Immunology.

[10]  S. Kaufmann,et al.  TLR3 regulates mycobacterial RNA-induced IL-10 production through the PI3K/AKT signaling pathway. , 2014, Cellular signalling.

[11]  G. Wong,et al.  Targeted prostaglandin E2 inhibition enhances antiviral immunity through induction of type I interferon and apoptosis in macrophages. , 2014, Immunity.

[12]  S. Kaufmann,et al.  Progress in tuberculosis vaccine development and host-directed therapies--a state of the art review. , 2014, The Lancet. Respiratory medicine.

[13]  B. Chain,et al.  HIV-1 infection of macrophages dysregulates innate immune responses to Mycobacterium tuberculosis by inhibition of interleukin-10. , 2014, The Journal of infectious diseases.

[14]  H. Mollenkopf,et al.  CXCL5-secreting pulmonary epithelial cells drive destructive neutrophilic inflammation in tuberculosis. , 2014, The Journal of clinical investigation.

[15]  Charles N Serhan,et al.  Resolution of acute inflammation in the lung. , 2014, Annual review of physiology.

[16]  S. Kaufmann,et al.  Reverse Translation in Tuberculosis: Neutrophils Provide Clues for Understanding Development of Active Disease , 2014, Front. Immunol..

[17]  T. Hussell,et al.  Alveolar macrophages: plasticity in a tissue-specific context , 2014, Nature Reviews Immunology.

[18]  JoAnne L. Flynn,et al.  Sterilization of granulomas is common in both active and latent tuberculosis despite extensive within-host variability in bacterial killing , 2013, Nature Medicine.

[19]  P. Cardona,et al.  Damaging role of neutrophilic infiltration in a mouse model of progressive tuberculosis. , 2014, Tuberculosis.

[20]  I. Orme.  A new unifying theory of the pathogenesis of tuberculosis. , 2014, Tuberculosis.

[21]  M. Selman,et al.  S100A8/A9 proteins mediate neutrophilic inflammation and lung pathology during tuberculosis. , 2013, American journal of respiratory and critical care medicine.

[22]  I. Orme,et al.  Gr1intCD11b+ Myeloid-Derived Suppressor Cells in Mycobacterium tuberculosis Infection , 2013, PloS one.

[23]  R. Wilkinson,et al.  Neutrophilia independently predicts death in tuberculosis , 2013, European Respiratory Journal.

[24]  F. Sutterwala,et al.  Cutting Edge: Mycobacterium tuberculosis but Not Nonvirulent Mycobacteria Inhibits IFN-β and AIM2 Inflammasome–Dependent IL-1β Production via Its ESX-1 Secretion System , 2013, The Journal of Immunology.

[25]  P. V. van Helden,et al.  Increased frequency of myeloid-derived suppressor cells during active tuberculosis and after recent mycobacterium tuberculosis infection suppresses T-cell function. , 2013, American journal of respiratory and critical care medicine.

[26]  D. Chaussabel,et al.  TPL-2–ERK1/2 Signaling Promotes Host Resistance against Intracellular Bacterial Infection by Negative Regulation of Type I IFN Production , 2013, The Journal of Immunology.

[27]  V. Pascual,et al.  Transcriptional Blood Signatures Distinguish Pulmonary Tuberculosis, Pulmonary Sarcoidosis, Pneumonias and Lung Cancers , 2013, PloS one.

[28]  Jin Hee Kim,et al.  Microenvironments in Tuberculous Granulomas Are Delineated by Distinct Populations of Macrophage Subsets and Expression of Nitric Oxide Synthase and Arginase Isoforms , 2013, The Journal of Immunology.

[29]  Denise E. Kirschner,et al.  Multi-Scale Modeling Predicts a Balance of Tumor Necrosis Factor-α and Interleukin-10 Controls the Granuloma Environment during Mycobacterium tuberculosis Infection , 2013, PloS one.

[30]  S. Way,et al.  Pathogen-specific Treg cells expand early during mycobacterium tuberculosis infection but are later eliminated in response to Interleukin-12. , 2013, Immunity.

[31]  Steven B. Bradfute,et al.  Autophagy as an immune effector against tuberculosis. , 2013, Current opinion in microbiology.

[32]  J. Ruland,et al.  Caspase recruitment domain-containing protein 9 signaling in innate immunity and inflammation. , 2013, Trends in immunology.

[33]  John H. White,et al.  Vitamin D Induces Interleukin-1β Expression: Paracrine Macrophage Epithelial Signaling Controls M. tuberculosis Infection , 2013, PLoS pathogens.

[34]  L. Ramakrishnan,et al.  TNF Dually Mediates Resistance and Susceptibility to Mycobacteria via Mitochondrial Reactive Oxygen Species , 2013, Cell.

[35]  A. Bernabé-Ortiz,et al.  Induced Sputum MMP-1, -3 & -8 Concentrations during Treatment of Tuberculosis , 2013, PloS one.

[36]  Ana C Anderson,et al.  IL-1β Promotes Antimicrobial Immunity in Macrophages by Regulating TNFR Signaling and Caspase-3 Activation , 2013, The Journal of Immunology.

[37]  J. Juarez,et al.  CD4+ cell-dependent granuloma formation in humanized mice infected with mycobacteria , 2013, Proceedings of the National Academy of Sciences.

[38]  S. Khader,et al.  Chemokines shape the immune responses to tuberculosis. , 2013, Cytokine & growth factor reviews.

[39]  Robert J Wilkinson,et al.  The immune response in tuberculosis. , 2013, Annual review of immunology.

[40]  Yue-Yun Ma,et al.  Autophagy protects type II alveolar epithelial cells from Mycobacterium tuberculosis infection. , 2013, Biochemical and biophysical research communications.

[41]  P. Kubes,et al.  Neutrophil recruitment and function in health and inflammation , 2013, Nature Reviews Immunology.

[42]  Pawan Gupta,et al.  Human IL10 Gene Repression by Rev-erbα Ameliorates Mycobacterium tuberculosis Clearance* , 2013, The Journal of Biological Chemistry.

[43]  M. Selman,et al.  CXCR5⁺ T helper cells mediate protective immunity against tuberculosis. , 2013, The Journal of clinical investigation.

[44]  D. Kirschner,et al.  Intracellular Bacillary Burden Reflects a Burst Size for Mycobacterium tuberculosis In Vivo , 2013, PLoS pathogens.

[45]  Hardy Kornfeld,et al.  Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome–dependent processing of IL-1β , 2012, Nature Immunology.

[46]  L. Ramakrishnan.  The zebrafish guide to tuberculosis immunity and treatment. , 2013, Cold Spring Harbor symposia on quantitative biology.

[47]  A. Mattos-Guaraldi,et al.  Arginase-1 expression in granulomas of tuberculosis patients. , 2012, FEMS immunology and medical microbiology.

[48]  V. Deretic,et al.  Autophagy protects against active tuberculosis by suppressing bacterial burden and inflammation , 2012, Proceedings of the National Academy of Sciences.

[49]  C. Khor,et al.  Genome-Wide Expression Profiling Identifies Type 1 Interferon Response Pathways in Active Tuberculosis , 2012, PloS one.

[50]  Barbara J. Reaves,et al.  The Role of Lipid Raft Aggregation in the Infection of Type II Pneumocytes by Mycobacterium tuberculosis , 2012, PloS one.

[51]  J. Cox,et al.  Extracellular M. tuberculosis DNA Targets Bacteria for Autophagy by Activating the Host DNA-Sensing Pathway , 2012, Cell.

[52]  J. Ernst.  The immunological life cycle of tuberculosis , 2012, Nature Reviews Immunology.

[53]  Dirk Repsilber,et al.  Biomarkers of Inflammation, Immunosuppression and Stress Are Revealed by Metabolomic Profiling of Tuberculosis Patients , 2012, PloS one.

[54]  J. Ernst,et al.  Dynamic Roles of Type I and Type II IFNs in Early Infection with Mycobacterium tuberculosis , 2012, The Journal of Immunology.

[55]  A. Lackner,et al.  The non‐human primate model of tuberculosis , 2012, Journal of medical primatology.

[56]  D. Portnoy,et al.  Mycobacterium tuberculosis activates the DNA-dependent cytosolic surveillance pathway within macrophages. , 2012, Cell host & microbe.

[57]  S. Kaufmann,et al.  Mycobacterium tuberculosis: success through dormancy. , 2012, FEMS microbiology reviews.

[58]  Stefan H. E. Kaufmann,et al.  Common patterns and disease-related signatures in tuberculosis and sarcoidosis , 2012, Proceedings of the National Academy of Sciences.

[59]  L. Ramakrishnan.  Revisiting the role of the granuloma in tuberculosis , 2012, Nature Reviews Immunology.

[60]  Yujiong Wang,et al.  The Role of Airway Epithelial Cells in Response to Mycobacteria Infection , 2012, Clinical & developmental immunology.

[61]  Catherine M Stein,et al.  Innate and adaptive immune responses during acute M. tuberculosis infection in adult household contacts in Kampala, Uganda. , 2012, The American journal of tropical medicine and hygiene.

[62]  John P. Ray,et al.  Host Genotype-Specific Therapies Can Optimize the Inflammatory Response to Mycobacterial Infections , 2012, Cell.

[63]  A. Pawłowski,et al.  Failure To Recruit Anti-Inflammatory CD103+ Dendritic Cells and a Diminished CD4+ Foxp3+ Regulatory T Cell Pool in Mice That Display Excessive Lung Inflammation and Increased Susceptibility to Mycobacterium tuberculosis , 2012, Infection and Immunity.

[64]  A. Sher,et al.  Innate and adaptive interferons suppress IL-1α and IL-1β production by distinct pulmonary myeloid subsets during Mycobacterium tuberculosis infection. , 2011, Immunity.

[65]  E. Pamer,et al.  Monocyte recruitment during infection and inflammation , 2011, Nature Reviews Immunology.

[66]  Dirk Repsilber,et al.  Functional Correlations of Pathogenesis-Driven Gene Expression Signatures in Tuberculosis , 2011, PloS one.

[67]  B. Nandi,et al.  Regulation of neutrophils by interferon-γ limits lung inflammation during tuberculosis infection , 2011, The Journal of experimental medicine.

[68]  M. Weller,et al.  An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor , 2011, Nature.

[69]  B. Hogan,et al.  Epithelial progenitor cells in lung development, maintenance, repair, and disease. , 2011, Annual review of cell and developmental biology.

[70]  T. Myers,et al.  This information is current as Production in Human Macrophages β Type I IFN Signaling To Regulate IL-1 Triggers Host Mycobacterium tuberculosis , 2011 .

[71]  A. Prince,et al.  Innate immunity in the respiratory epithelium. , 2011, American journal of respiratory cell and molecular biology.

[72]  G. Kaplan,et al.  Phosphodiesterase-4 inhibition combined with isoniazid treatment of rabbits with pulmonary tuberculosis reduces macrophage activation and lung pathology. , 2011, The American journal of pathology.

[73]  J. Keane,et al.  IL-10 blocks phagosome maturation in mycobacterium tuberculosis-infected human macrophages. , 2011, American journal of respiratory cell and molecular biology.

[74]  Simeone Marino,et al.  A multifaceted approach to modeling the immune response in tuberculosis , 2011, Wiley interdisciplinary reviews. Systems biology and medicine.

[75]  J. Ernst,et al.  Lung Neutrophils Facilitate Activation of Naive Antigen-Specific CD4+ T Cells during Mycobacterium tuberculosis Infection , 2011, The Journal of Immunology.

[76]  P. Barnes,et al.  Programmed death 1 and cytokine inducible SH2-containing protein dependent expansion of regulatory T cells upon stimulation With Mycobacterium tuberculosis. , 2011, The Journal of infectious diseases.

[77]  A. Sher,et al.  Role of innate cytokines in mycobacterial infection , 2011, Mucosal Immunology.

[78]  M. Oosting,et al.  Innate Immune Recognition of Mycobacterium tuberculosis , 2011, Clinical & developmental immunology.

[79]  A. O’Garra,et al.  The role of IL-10 in immune regulation during M. tuberculosis infection , 2011, Mucosal Immunology.

[80]  D. Lewinsohn,et al.  Views of immunology: effector T cells , 2011, Immunological reviews.

[81]  Dongwan D. Kang,et al.  Profiling Early Lung Immune Responses in the Mouse Model of Tuberculosis , 2011, PloS one.

[82]  D Repsilber,et al.  Human gene expression profiles of susceptibility and resistance in tuberculosis , 2011, Genes and Immunity.

[83]  A. Cooper,et al.  IL-17 and Th17 cells in tuberculosis. , 2010, Cytokine & growth factor reviews.

[84]  D. Havlir,et al.  Significant variation in presentation of pulmonary tuberculosis across a high resolution of CD4 strata. , 2010, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[85]  C. Serrano,et al.  Kinetics and cellular sources of cathelicidin during the course of experimental latent tuberculous infection and progressive pulmonary tuberculosis , 2010, Clinical and experimental immunology.

[86]  H. Weiner,et al.  Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell–like and Foxp3+ regulatory T cells , 2010, Nature Immunology.

[87]  H. Mollenkopf,et al.  Serine protease activity contributes to control of Mycobacterium tuberculosis in hypoxic lung granulomas in mice. , 2010, The Journal of clinical investigation.

[88]  D. Kaushal,et al.  Transcriptional Reprogramming in Nonhuman Primate (Rhesus Macaque) Tuberculosis Granulomas , 2010, PloS one.

[89]  G. Kaplan,et al.  Arginine Usage in Mycobacteria-Infected Macrophages Depends on Autocrine-Paracrine Cytokine Signaling , 2010, Science Signaling.

[90]  Murugesan V. S. Rajaram,et al.  Mycobacterium tuberculosis Activates Human Macrophage Peroxisome Proliferator-Activated Receptor γ Linking Mannose Receptor Recognition to Regulation of Immune Responses , 2010, The Journal of Immunology.

[91]  H. Weiner,et al.  The Aryl hydrocarbon Receptor (AhR) interacts with c-Maf to promote the differentiation of IL-27-induced regulatory type 1 (TR1) cells , 2010, Nature Immunology.

[92]  K. Takatsu,et al.  Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis , 2010, The Journal of experimental medicine.

[93]  G. Kaplan,et al.  Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism , 2010, EMBO molecular medicine.

[94]  Virginia Pascual,et al.  An Interferon-Inducible Neutrophil-Driven Blood Transcriptional Signature in Human Tuberculosis , 2010, Nature.

[95]  G. Bancroft,et al.  Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung , 2010, European journal of immunology.

[96]  Matthew S. Cook,et al.  Human Mucosal Associated Invariant T Cells Detect Bacterially Infected Cells , 2010, PLoS biology.

[97]  David G. Russell,et al.  Tuberculosis: What We Don’t Know Can, and Does, Hurt Us , 2010, Science.

[98]  A. Sher,et al.  Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population. , 2010, The Journal of clinical investigation.

[99]  H. Mollenkopf,et al.  The adaptor molecule CARD9 is essential for tuberculosis control , 2010, The Journal of experimental medicine.

[100]  M. Quail,et al.  Tuberculous Granuloma Induction via Interaction of a Bacterial Secreted Protein with Host Epithelium , 2010, Science.

[101]  P. Andersen,et al.  Potential role for ESAT6 in dissemination of M. tuberculosis via human lung epithelial cells , 2010, Molecular microbiology.

[102]  Sang-Nae Cho,et al.  Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB. , 2010, Chest.

[103]  J. Ernst,et al.  Interferon-gamma-responsive nonhematopoietic cells regulate the immune response to Mycobacterium tuberculosis. , 2009, Immunity.

[104]  C. Leclerc,et al.  Coactivation of Syk kinase and MyD88 adaptor protein pathways by bacteria promotes regulatory properties of neutrophils. , 2009, Immunity.

[105]  M. Munder.  Arginase: an emerging key player in the mammalian immune system , 2009, British Journal of Pharmacology.

[106]  D. Vestweber,et al.  A murine DC-SIGN homologue contributes to early host defense against Mycobacterium tuberculosis , 2009, The Journal of experimental medicine.

[107]  S. Ehlers,et al.  Autocrine IL-10 Induces Hallmarks of Alternative Activation in Macrophages and Suppresses Antituberculosis Effector Mechanisms without Compromising T Cell Immunity1 , 2009, The Journal of Immunology.

[108]  H. Bang,et al.  Tuberculosis Is Associated with a Down-Modulatory Lung Immune Response That Impairs Th1-Type Immunity1 , 2009, The Journal of Immunology.

[109]  S. Fortune,et al.  Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair , 2009, Nature Immunology.

[110]  S. Gordon,et al.  Alternative activation of macrophages: an immunologic functional perspective. , 2009, Annual review of immunology.

[111]  I. Orme,et al.  Lack of IL-10 alters inflammatory and immune responses during pulmonary Mycobacterium tuberculosis infection. , 2009, Tuberculosis.

[112]  Srinivas Nagaraj,et al.  Myeloid-derived suppressor cells as regulators of the immune system , 2009, Nature Reviews Immunology.

[113]  R. Reljic,et al.  TNF-α in Tuberculosis: A Cytokine with a Split Personality , 2009 .

[114]  Minjian Chen,et al.  Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death , 2008, The Journal of experimental medicine.

[115]  R. Wilkinson,et al.  Non-Opsonic Recognition of Mycobacterium tuberculosis by Phagocytes , 2008, Journal of Innate Immunity.

[116]  G. Kaplan,et al.  Toll-like receptor–induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens , 2008, Nature Immunology.

[117]  R. Wallis.  Tumour necrosis factor antagonists: structure, function, and tuberculosis risks. , 2008, The Lancet. Infectious diseases.

[118]  Hannah E. Volkman,et al.  Tumor necrosis factor signaling mediates resistance to mycobacteria by inhibiting bacterial growth and macrophage death. , 2008, Immunity.

[119]  R. Basaraba.  Experimental tuberculosis: the role of comparative pathology in the discovery of improved tuberculosis treatment strategies. , 2008, Tuberculosis.

[120]  P. Hopewell,et al.  Tuberculosis and latent tuberculosis infection in close contacts of people with pulmonary tuberculosis in low-income and middle-income countries: a systematic review and meta-analysis. , 2008, The Lancet. Infectious diseases.

[121]  R. Hernández-Pando,et al.  The Potential Role of Lung Epithelial Cells and β‐defensins in Experimental Latent Tuberculosis , 2008, Scandinavian journal of immunology.

[122]  J. Buer,et al.  The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins , 2008, Nature.

[123]  H. Weiner,et al.  Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor , 2008, Nature.

[124]  Ronald N Germain,et al.  Macrophage and T cell dynamics during the development and disintegration of mycobacterial granulomas. , 2008, Immunity.

[125]  N. Reiling,et al.  MyDths and un-TOLLed truths: sensor, instructive and effector immunity to tuberculosis. , 2008, Immunology letters.

[126]  Sugata Roy,et al.  Mannose‐capped lipoarabinomannan‐ and prostaglandin E2‐dependent expansion of regulatory T cells in human Mycobacterium tuberculosis infection , 2008, European journal of immunology.

[127]  S. Khader,et al.  IL-23 and IL-17 in tuberculosis. , 2008, Cytokine.

[128]  P. Holt,et al.  Regulation of immunological homeostasis in the respiratory tract , 2008, Nature Reviews Immunology.

[129]  M. Torres,et al.  Expression of Cathelicidin LL-37 during Mycobacterium tuberculosis Infection in Human Alveolar Macrophages, Monocytes, Neutrophils, and Epithelial Cells , 2007, Infection and Immunity.

[130]  J. Ernst,et al.  Mycobacterium tuberculosis Infects Dendritic Cells with High Frequency and Impairs Their Function In Vivo1 , 2007, The Journal of Immunology.

[131]  R. Modlin,et al.  Cutting Edge: Vitamin D-Mediated Human Antimicrobial Activity against Mycobacterium tuberculosis Is Dependent on the Induction of Cathelicidin1 , 2007, The Journal of Immunology.

[132]  Sugata Roy,et al.  Pulmonary epithelial cells are a source of interferon‐γ in response to Mycobacterium tuberculosis infection , 2007, Immunology and cell biology.

[133]  J. Johndrow,et al.  The Type I IFN Response to Infection with Mycobacterium tuberculosis Requires ESX-1-Mediated Secretion and Contributes to Pathogenesis1 , 2007, The Journal of Immunology.

[134]  D. Quiceno,et al.  L-arginine availability regulates T-lymphocyte cell-cycle progression. , 2007, Blood.

[135]  A. Sher,et al.  NK Cell-Derived IFN-γ Differentially Regulates Innate Resistance and Neutrophil Response in T Cell-Deficient Hosts Infected with Mycobacterium tuberculosis , 2006, The Journal of Immunology.

[136]  J. Flynn,et al.  IL-17 Production Is Dominated by γδ T Cells rather than CD4 T Cells during Mycobacterium tuberculosis Infection1 , 2006, The Journal of Immunology.

[137]  Angelo A. Izzo,et al.  Role for Matrix Metalloproteinase 9 in Granuloma Formation during Pulmonary Mycobacterium tuberculosis Infection , 2006, Infection and Immunity.

[138]  V. Tsutsumi,et al.  beta-Defensin gene expression during the course of experimental tuberculosis infection. , 2006, The Journal of infectious diseases.

[139]  A. Azad,et al.  Fine Discrimination in the Recognition of Individual Species of Phosphatidyl-myo-Inositol Mannosides from Mycobacterium tuberculosis by C-Type Lectin Pattern Recognition Receptors1 , 2006, The Journal of Immunology.

[140]  S. Ehlers,et al.  Granulocytes Accelerated and Enhanced Recruitment of Tuberculosis in Mice Causally Involves Genetically Determined Susceptibility To , 2022 .

[141]  Jean-Louis Herrmann,et al.  DC-SIGN Induction in Alveolar Macrophages Defines Privileged Target Host Cells for Mycobacteria in Patients with Tuberculosis , 2005, PLoS medicine.

[142]  A. Azad,et al.  The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis , 2005, The Journal of experimental medicine.

[143]  S. Kaufmann,et al.  Mycobacterium tuberculosis and the host response , 2005, The Journal of experimental medicine.

[144]  A. Apt,et al.  Neutrophil Responses to Mycobacterium tuberculosis Infection in Genetically Susceptible and Resistant Mice , 2005, Infection and Immunity.

[145]  Pam Sonnenberg,et al.  How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners. , 2005, The Journal of infectious diseases.

[146]  Sugata Roy,et al.  Induction of nitric oxide release from the human alveolar epithelial cell line A549: an in vitro correlate of innate immune response to Mycobacterium tuberculosis , 2004, Immunology.

[147]  Jasim Uddin,et al.  Transcriptional Mechanisms Regulating Alveolar Epithelial Cell-specific CCL5 Secretion in Pulmonary Tuberculosis* , 2004, Journal of Biological Chemistry.

[148]  Jennifer L. Martin,et al.  Complement Protein C3 Binding to Mycobacterium tuberculosis Is Initiated by the Classical Pathway in Human Bronchoalveolar Lavage Fluid , 2004, Infection and Immunity.

[149]  N. Boéchat,et al.  Down-Modulation of Lung Immune Responses by Interleukin-10 and Transforming Growth Factor β (TGF-β) and Analysis of TGF-β Receptors I and II in Active Tuberculosis , 2004, Infection and Immunity.

[150]  P. Allavena,et al.  From pattern recognition receptor to regulator of homeostasis: the double-faced macrophage mannose receptor. , 2004, Critical reviews in immunology.

[151]  G. Kaplan,et al.  Mycobacterium tuberculosis Growth at theCavity Surface: a Microenvironment with FailedImmunity , 2003, Infection and Immunity.

[152]  P. Allavena,et al.  Cross-Linking of the Mannose Receptor on Monocyte-Derived Dendritic Cells Activates an Anti-Inflammatory Immunosuppressive Program 1 , 2003, The Journal of Immunology.

[153]  D. Eisenberg,et al.  The primary mechanism of attenuation of bacillus Calmette–Guérin is a loss of secreted lytic function required for invasion of lung interstitial tissue , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[154]  H. Mollenkopf,et al.  Early granuloma formation after aerosol Mycobacterium tuberculosis infection is regulated by neutrophils via CXCR3‐signaling chemokines , 2003, European journal of immunology.

[155]  A. González-Arenas,et al.  Macrophage--Mycobacterium tuberculosis interactions: role of complement receptor 3. , 2003, Microbial pathogenesis.

[156]  Yu-Jin Jung,et al.  Increased interleukin‐10 expression is not responsible for failure of T helper 1 immunity to resolve airborne Mycobacterium tuberculosis infection in mice , 2003, Immunology.

[157]  S. Kaufmann,et al.  T-Cell Responses to CD1-Presented Lipid Antigens in Humans with Mycobacterium tuberculosis Infection , 2003, Infection and Immunity.

[158]  T. Geijtenbeek,et al.  Mycobacteria Target DC-SIGN to Suppress Dendritic Cell Function , 2003, The Journal of experimental medicine.

[159]  Carl Nathan,et al.  Points of control in inflammation , 2002, Nature.

[160]  I. Maridonneau-Parini,et al.  Complement Receptor 3 (CD11b/CD18) Mediates Type I and Type II Phagocytosis During Nonopsonic and Opsonic Phagocytosis, Respectively1 , 2002, The Journal of Immunology.

[161]  F. Quinn,et al.  Demonstration of spread by Mycobacterium tuberculosis bacilli in A549 epithelial cell monolayers. , 2002, FEMS microbiology letters.

[162]  Andrew G. D. Bean,et al.  TNF Regulates Chemokine Induction Essential for Cell Recruitment, Granuloma Formation, and Clearance of Mycobacterial Infection1 , 2002, The Journal of Immunology.

[163]  C. Sano,et al.  Type II alveolar cells play roles in macrophage-mediated host innate resistance to pulmonary mycobacterial infections by producing proinflammatory cytokines. , 2002, The Journal of infectious diseases.

[164]  C. Demangel,et al.  Autocrine IL‐10 impairs dendritic cell (DC)‐derived immune responses to mycobacterial infection by suppressing DC trafficking to draining lymph nodes and local IL‐12 production , 2002, European journal of immunology.

[165]  T. Ottenhoff,et al.  Innate Immunity to Mycobacterium tuberculosis , 2002, Clinical Microbiology Reviews.

[166]  L. Bermudez,et al.  The Efficiency of the Translocation of Mycobacterium tuberculosis across a Bilayer of Epithelial and Endothelial Cells as a Model of the Alveolar Wall Is a Consequence of Transport within Mononuclear Phagocytes and Invasion of Alveolar Epithelial Cells , 2002, Infection and Immunity.

[167]  G. Puzo,et al.  Mannosylated Lipoarabinomannans Inhibit IL-12 Production by Human Dendritic Cells: Evidence for a Negative Signal Delivered Through the Mannose Receptor1 , 2001, The Journal of Immunology.

[168]  G. Kaplan,et al.  Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-α/β , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[169]  T. van der Poll,et al.  Protective Effects in Pulmonary Tuberculosis Depletion of Alveolar Macrophages Exerts , 2001 .

[170]  R. Stokes,et al.  Utilization of CD11b knockout mice to characterize the role of complement receptor 3 (CR3, CD11b/CD18) in the growth of Mycobacterium tuberculosis in macrophages. , 2000, Cellular immunology.

[171]  J. Chan,et al.  Mycobacterium tuberculosis Infection in Complement Receptor 3-Deficient Mice1 , 2000, The Journal of Immunology.

[172]  J. Friedland,et al.  Regulation of IL-10 secretion after phagocytosis of Mycobacterium tuberculosis by human monocytic cells. , 2000, Cytokine.

[173]  B. Hamilton,et al.  Interaction of Mycobacterium tuberculosis-Induced Transforming Growth Factor β1 and Interleukin-10 , 1999, Infection and Immunity.

[174]  J. Friedland,et al.  Pulmonary epithelial cells are a source of IL-8 in the response to Mycobacterium tuberculosis: essential role of IL-1 from infected monocytes in a NF-kappa B-dependent network. , 1999, Journal of immunology.

[175]  G. Trinchieri,et al.  CD4+ T Cell Clones Producing both Interferon-γ and Interleukin-10 Predominate in Bronchoalveolar Lavages of Active Pulmonary Tuberculosis Patients , 1999 .

[176]  R. Young,et al.  Increased Antimycobacterial Immunity in Interleukin-10-Deficient Mice , 1999, Infection and Immunity.

[177]  T. Udagawa,et al.  Role of tumor necrosis factor-alpha in Mycobacterium-induced granuloma formation in tumor necrosis factor-alpha-deficient mice. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[178]  J. Sedgwick,et al.  Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. , 1999, Journal of immunology.

[179]  I. Maridonneau-Parini,et al.  The Mannose Receptor Mediates Uptake of Pathogenic and Nonpathogenic Mycobacteria and Bypasses Bactericidal Responses in Human Macrophages , 1999, Infection and Immunity.

[180]  G. Trinchieri,et al.  CD4(+) T cell clones producing both interferon-gamma and interleukin-10 predominate in bronchoalveolar lavages of active pulmonary tuberculosis patients. , 1999, Clinical immunology.

[181]  A. Aderem,et al.  Mechanisms of phagocytosis in macrophages. , 1999, Annual review of immunology.

[182]  J. Ernst,et al.  Macrophage Receptors for Mycobacterium tuberculosis , 1998, Infection and Immunity.

[183]  P. Barnes,et al.  Chemokine Production by a Human Alveolar Epithelial Cell Line in Response to Mycobacterium tuberculosis , 1998, Infection and Immunity.

[184]  M. Daffé,et al.  Nonopsonic binding of Mycobacterium tuberculosis to complement receptor type 3 is mediated by capsular polysaccharides and is strain dependent , 1997, Infection and immunity.

[185]  E. Brown,et al.  A macrophage invasion mechanism of pathogenic mycobacteria. , 1997, Science.

[186]  J. Caylà,et al.  Characteristics of tuberculosis patients who generate secondary cases. , 1997, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[187]  R. Young,et al.  T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection. , 1997, Journal of immunology.

[188]  D. Russell,et al.  The interaction between Mycobacterium and the macrophage analyzed by two‐dimensional polyacrylamide gel electrophoresis , 1997, Electrophoresis.

[189]  T. Mak,et al.  Corynebacterium parvum- and Mycobacterium bovis bacillus Calmette-Guerin-induced granuloma formation is inhibited in TNF receptor I (TNF-RI) knockout mice and by treatment with soluble TNF-RI. , 1996, Journal of immunology.

[190]  J. Ernst,et al.  Selective receptor blockade during phagocytosis does not alter the survival and growth of Mycobacterium tuberculosis in human macrophages. , 1996, American journal of respiratory cell and molecular biology.

[191]  R. Kirsch,et al.  Nonopsonic binding of Mycobacterium tuberculosis to human complement receptor type 3 expressed in Chinese hamster ovary cells , 1996, Infection and immunity.

[192]  Y. McCarter,et al.  Quality evaluation of sputum specimens for mycobacterial culture. , 1996, American journal of clinical pathology.

[193]  H. Shiratsuchi,et al.  Selective induction of transforming growth factor beta in human monocytes by lipoarabinomannan of Mycobacterium tuberculosis , 1996, Infection and immunity.

[194]  S. Kaufmann,et al.  Protective role of γ/δ T cells and α/β T cells in tuberculosis , 1995 .

[195]  H. Shiratsuchi,et al.  Enhanced production of TGF-beta by blood monocytes from patients with active tuberculosis and presence of TGF-beta in tuberculous granulomatous lung lesions. , 1995, Journal of immunology.

[196]  Z. Toossi,et al.  Enhancement of intracellular growth of Mycobacterium tuberculosis in human monocytes by transforming growth factor-beta 1. , 1994, The Journal of infectious diseases.

[197]  J. Abrams,et al.  Cytokine production at the site of disease in human tuberculosis , 1993, Infection and immunity.

[198]  L. Schlesinger.  Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. , 1993, Journal of immunology.

[199]  M. Roth,et al.  Human pulmonary macrophages utilize prostaglandins and transforming growth factor β1 to suppress lymphocyte activation , 1993, Journal of leukocyte biology.

[200]  J. Flynn,et al.  Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[201]  J. Abrams,et al.  γδ T Lymphocytes in Human Tuberculosis , 1992 .

[202]  S. Kaufmann,et al.  Gamma interferon and interleukin 2, but not interleukin 4, are detectable in gamma/delta T-cell cultures after activation with bacteria , 1992, Infection and immunity.

[203]  T. Mosmann,et al.  IL-10 inhibits cytokine production by activated macrophages. , 1991, Journal of immunology.

[204]  R. Derynck,et al.  Macrophage deactivating factor and transforming growth factors-beta 1 -beta 2 and -beta 3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-gamma. , 1990, Journal of immunology.

[205]  M. Horwitz,et al.  Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. , 1990, Journal of immunology.

[206]  V. Kindler,et al.  The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection , 1989, Cell.

[207]  G. Toews,et al.  Inability of human alveolar macrophages to stimulate resting T cells correlates with decreased antigen-specific T cell-macrophage binding. , 1986, Journal of immunology.

[208]  R. Crystal,et al.  Normal human alveolar macrophages obtained by bronchoalveolar lavage have a limited capacity to release interleukin-1. , 1984, The Journal of clinical investigation.

[209]  H. Verbrugh,et al.  Differences in phagocytosis and killing by alveolar macrophages from humans, rabbits, rats, and hamsters , 1982, Infection and immunity.

[210]  P. Holt.  Alveolar macrophages. III. Studies on the mechanisms of inhibition of T-cell proliferation. , 1979, Immunology.

[211]  A. Dannenberg,et al.  Liquefaction of caseous foci in tuberculosis. , 1976, The American review of respiratory disease.

[212]  V. Houk,et al.  The epidemiology of tuberculosis infection in a closed environment. , 1968, Archives of environmental health.

[213]  M. L. Karnovsky,et al.  METABOLIC PATTERNS IN THREE TYPES OF PHAGOCYTIZING CELLS , 1963, The Journal of cell biology.

[214]  H. Israel,et al.  A STUDY OF TUBERCULOSIS AMONG STUDENTS OF NURSING , 1941 .

[215]  W. L. Mallmann.  A BACTERIOLOGIC STUDY OF A NEW SANIGENIC FLOORING , 1941 .

[216]  Albert Moegling,et al.  Die Säuglingstuberkulose in Lübeck: Zusammenfassung der Anlässlich der Lübecker Säuglingserkrankungen auf Veranlassung und mit Unterstützung des Reichsministeriums des Inneren Durchgeführten Untersuchungen , 1935 .

[217]  M. Greenwood.  PROFESSOR CALMETTE'S STATISTICAL STUDY OF B.C.G. VACCINATION , 1928, British medical journal.